Drugs / cellular immunotherapy
last change Jun 2015 re-read 3 minutes ago

cellular immunotherapy

Cell therapy

Developed for
acute leukemia · Burkitt lymphoma · diffuse large B-cell lymphoma · mantle cell lymphoma · T-cell non-Hodgkin lymphoma
Investigated by
Brown University

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01685606 Mar 2013 → Jun 2015 Burkitt lymphoma, T-cell non-Hodgkin lymphoma, acute leukemia, diffuse large B-cell lymphoma +1 Brown University Terminated No outcome recorded Stop: Enrollment

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as cellular immunotherapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT01685606 ↗
Modality Cell therapy “cellular therapy” PMID 23782682 ↗ Jun 2013